企业创立之初
Osstell 是专攻种植体稳定性测定与骨整合进程监测的全球领导者。Osstell成立于1999年,旨在通过共振频率分析(RFA)将尖端的技术发明商业化,用于精准确定牙科种植体的临床状态。超过1300份科学出版刊物证实了这项技术助益良多,其临床价值巨大,并且ISQ量表在牙科医生的日常执业中用处广泛。Osstell 总部位于牙科种植体的发源地——瑞典哥德堡。自2018年以来,Osstell隶属于W&H集团,该集团是世界领先的牙科精密器械和设备制造商之一。

超过20年的经验

行业领导者

超过1300篇科学出版物


安全
我们的方法可排除偶然机会。在测定种植体稳定性时,您将获得客观值,从而使种植体治疗更具可预测性——即使对于有风险因素的患者也是如此。

缩短治疗时间
即刻负重的需求越来越常见。患者希望快速获得立竿见影的效果。使用Osstell®,避免无效等待时间。

可靠的方法
我们的方法基于RFA,依托1300多项科学研究成果,可确定种植体是否足够稳定。结果显示为 1-100 的ISQ值。ISQ 越高,种植体越稳定。
科学顾问

Prof. Daniel Buser
Professor and Chairman, Dept. of Oral Surgery and Stomatology, School of Dental Medicine, University of Bern, Switzerland

Prof. Peter K. Moy
Oral & Maxillofacial Surgeon, Professor, Oral & Maxillofacial Surgery, UCLA, Los Angeles, USA, Director, Implant Dentistry

Dr. Marcus Dagnelid
DDS, Board Certified Prosthodontist
CEO, Chief of Staff, Dagnelid Clinic & Falkenberg Clinic, SAACD AB
CEO, European Dental Academy

Prof. Neil Meredith
Professor in Prosthodontics, University of Queensland, Brisbane, Australia
董事会成员

Klaus Maier
Chairman of the Board
Background: International experiences in leading positions in aeronautic and health care industries. Vice President Finance and Distribution for the W&H Group since 2009.
Other assignments: CEO of W&H Sterilization S.r.l., major roles and assignments in several other W&H companies

Martin Schwenoha
Background: More than 30 years experience in the W&H Group in different leading positions.
Vice President Group Operations for the W&H Group since 2020.

Jonas Ehinger
Background: More than 25 years of experience in the life science and MedTech industry with leading and CEO positions in growth companies such as Applied Biosystems, Kovalent, Cellectricon and Mentice.
Other assignments:
Board member, Leading Light AB
Chairman of the Board, Gapwaves AB
Board Member, Doxa AB
管理团队